RICE HALL JAMES & ASSOCIATES, LLC
Position in ACAD — Acadia Pharmaceuticals Inc
CIK 1230765
San Diego, CA
Position in ACAD
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$15,657,841
+$1,912,536 QoQ
Shares Held
618,887
+0.2% QoQ
Ownership
0.359%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
#40
of 350 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RICE HALL JAMES & ASSOCIATES, LLC holds $259,930,953 across 19 Biotechnology names. ACAD ranks #4 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
270,052 | $85,360,736 | |
| 2 | ASND |
Ascendis Pharma A/S
|
148,644 | $39,646,327 | |
| 3 | VRDN |
Viridian Therapeutics, Inc.\DE
|
1,175,906 | $21,601,393 | |
| 4 | ACAD |
Acadia Pharmaceuticals Inc
This page
|
618,887 | $15,657,841 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
248,224 | $14,203,377 | |
| 6 | TSHA |
Taysha Gene Therapies, Inc.
|
1,992,229 | $13,567,079 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
110,673 | $12,956,488 | |
| 8 | URGN |
UroGen Pharma Ltd.
|
300,650 | $11,063,920 |
All Filings in ACAD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,657,841 | 618,887 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $13,745,305 | 617,489 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $16,125,895 | 603,740 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $13,122,755 | 614,937 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $14,447,715 | 669,806 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $11,165,624 | 672,223 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $12,506,203 | 681,537 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $11,029,705 | 717,146 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $12,072,693 | 742,935 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $12,287,640 | 664,556 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $21,693,196 | 692,852 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $14,505,994 | 696,065 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $21,230,549 | 886,453 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $16,695,711 | 887,126 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $15,246,392 | 957,688 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $8,570,513 | 523,870 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $7,658,309 | 543,528 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $11,221,222 | 463,304 | Shares | Sole | 2022-05-26 | |
| 2021-12-31 | $10,760,930 | 461,051 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,251,133 | 496,757 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $12,509,191 | 512,882 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $14,807,548 | 573,936 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $14,656,540 | 274,159 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $11,342,883 | 274,979 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $9,304,204 | 191,958 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $8,285,013 | 196,095 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||